• Consumer Stories
  • Partnering with Genoa
  • People-first Pharmacy Care

1,000 consumers stay on their treatment because one Genoa Healthcare pharmacy team stepped up

Sep 27th, 2024

After a large long-term care pharmacy in Anchorage, Alaska unexpectedly announced its closure earlier this year, patients across the state were left unsure of where they could get the medications they needed.

Genoa Healthcare pharmacist Yunga Vercelline, RPh made it her mission to keep impacted people on their treatment. In two months, she and her pharmacy team grew in size to begin serving over 1,000 new consumers.

To do this was no easy task. Beyond increasing the size of their staff, the team collaborated with the state to ensure Genoa’s Washington-based pharmacists and pharmacy technicians could practice in Alaska and provide them back up. Yunga also partnered with leaders of Alaska Behavioral Health, the clinic where her pharmacy is located, to expand Genoa’s pharmacy space so they had enough room to stock and fill medication for their new consumers.

“When there’s a crisis, the community comes together and does what needs to be done to help each other out,” said Yunga. “And I think that’s what we did.”

Learn more

Want to learn more about how Genoa can support your staff and consumers? Fill out the form and we’ll be in touch.

"*" indicates required fields

Name*
Does your organization currently partner with Genoa?*
This field is for validation purposes and should be left unchanged.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...